A five-minute delay in the clamping of healthy infants' umbilical cords results in increased iron stores and brain myelin in areas important for early-life functional development, a new University of Rhode Island nursing study has found.
An unexpected finding in preclinical platelet studies by Baker Institute researchers could provide a novel approach to targeting and destroying difficult-to-treat cancer cells, providing new therapeutic options for a range of cancers.
Blood cells could hold the key to aging, according to new research out of Case Western Reserve University School of Medicine. In a study published in Aging Cell, researchers found human blood cells have an intrinsic clock that remains steady even after transplant. The researchers say the clock could control human aging and may underlie blood cancers.
A brand new type of cancer drug that acts as a 'Trojan horse' to get inside tumor cells has shown promise in patients with six different cancer types.
When a patient has an intracerebral hemorrhage, surgeons need to remove at least 70 percent of it to reach a meaningful recovery. Ideally, there should be 15 milliliters or less of blood at the site of the injury.
The immunotherapy that has revolutionized treatment of many cancers appears to offer similar benefit to cancer patients living with HIV.
It is estimated that 3 million Americans live with inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC). Currently, there are no cures for these diseases. For many patients, their disease impacts other areas of their health and well-being, including aspects of their reproductive and mental health. Studies being presented at the Crohn's & Colitis highlights the need to treat the entire patient and reinforces the role of patient-provider communication.
It is estimated that 3 million Americans live with inflammatory bowel disease, including Crohn's disease and ulcerative colitis. Currently, there are no cures for these diseases. For many patients the path to diagnosis and effective treatment is long and arduous, leading to delayed treatment and increased complications. Studies being presented at the Crohn's & Colitis Congress reinforce the need for and highlight advances towards improved diagnosis of patients with IBD.
It is estimated that 3 million Americans live with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. Currently, there are no cures for these diseases. Studies being presented at the Crohn's & Colitis Congress -- a partnership of the Crohn's & Colitis Foundation and the American Gastroenterological Association, in Las Vegas, Nev., from Feb. 7-9 - highlight advancements in treatments for patients with IBD.
Almost three quarters (70 percent) of biomedical research papers do not report outcomes for men and women, according to a new analysis of over 11.5 million medical research papers published between 1980 and 2016. Additionally, female authors were more likely to report on sex-differences, highlighting that diversity in the workforce -- as well as the research population -- is essential to produce the most rigorous and effective research.